This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reichel, H., H.P. Koeffler, and A.W. Norman, The role of the vitamin D endocrine system in health and disease, N. Engl. J. Med. 320:980 (1989).
Abe, E., C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, and T. Suda, Differentiation of mouse myeloid leukemia cells induced by lά,25-dihydroxy-vitamin D3, Proc. Natl. Acad. Sci. USA 78:4990 (1981).
Munker, R., A.W. Norman, and H.P. Koeffler, Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells, J. Clin. Invest. 78:424 (1986).
Koeffler, H.P., K. Hirji, and L. Itri, 1,25-Dihydroxyvitamin D3: in vivo and in vitro effect on human preleukemic and leukemic cells, Cancer Treat. Rep. 69:1399 (1985).
Dodd, R.C., M.S. Cohen, S.L. Newman, and T.K. Gray, Vitamin D metabolites change the phenotype of monoblastic U937 cells, Proc. Natl. Acad. Sci. USA 80:7538 (1983).
Tanaka, H., E. Abe, C. Miyaura, Y. Shiina, and T. Suda, lά,25-Dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages but not into granulocytes, Biochem. Biophys. Res. Commun. 117:86 (1983).
Simpson, R.U., T. Hsu, D.A. Begley, B.S. Mitchell, and B.N. Alizadeh, Transcriptional regulation of the c-myc protooncogene by 1,25-dihydroxyvitamin D3 in HL-60 promyelocytic leukemia cells, J. Biol. Chem. 262:4104 (1987).
Brevli, Z.S. and G.P. Studzinksi, Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL60 cells, J. Cell. Biol. 102:2234 (1986).
Ostrem, V.K., Y. Tanaka, J. Prahl, H.R DeLuca, and N. Ikekawn, 24-and 26-homo-l,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro, Proc. Natl. Acad. Sci. USA 84:2610 (1987).
Perlman, K., A. Kutner, J. Prahl, C. Smith, M. Inaba, H.K. Schnoes, and H.F. DeLuca, 24 Homologated 1,25-dihydroxyvitamin D3 compounds: separation of calcium and cell differentiation activities, Biochemistry 29:190 (1990).
Zhou, J.Y., A.W. Norman, M. Lubbert, E.D. Collins, M.R. Uskokovic, and H.P. Koeffler, Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization, Blood 74:82 (1989).
Zhou, J.Y., A.W. Norman, D.-L. Chen, G.-W. Sun, M. Uskokovic, and H.P. Koeffler, 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice, Proc. Natl. Acad. Sci. USA 87:3929 (1990).
Abe, J., M. Morikawa, K. Miyamoto, S. Kaiho, M. Fukushima, C. Miyaura, E. Abe, T. Suda, and Y. Nishii, Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton, FEBS Lett. 226:58 (1987).
Wang, Y.-Z., H. Li, M.E. Bruns, M. Uskokovic, G.A. Truitt, R. Horst, T. Reinhardt, and S. Christakos, Effect of 1,25,28-trihydroxyvitamin D2 and 1,24,25-trihydroxyvitamin D3 on intestinal calbindin-D9k mRNA and protein: is there a correlation with intestinal calcium transport?, J. Bone Min. Res. 8:1483 (1993).
Colston, K., M.J. Colston, and D. Feldman, 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture, Endocrinology 108:1083(1981).
Frampton, R.J., S.A. Omond, and J.A. Eisman, Inhibition of human cancer cell growth by 1,25-dihydroxy vitamin D3 metabolites, Cancer Res. 43:4443 (1983).
Eisman, J.A., T.J. Martin, I. MacIntyre, and J.M. Moseley, 1,25-Dihydroxyvitamin D3 receptors in breast cancer cells, Lancet ii:1335 (1979).
Brehier, A. and M. Thomassett, Human colon cell line HT-29: characterization of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone, J. Steroid Biochem. 29:265 (1988).
Colston, K.W., U. Berger, and R. C. Coombes, Possible role for vitamin D in controlling breast cancer cell proliferation, Lancet i:188 (1989).
Colston, K.W., A.G. Mackay, S.Y. James, L. Binderup, S. Chander, and R.C. Coombes, EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro, Biochem. Pharmacol. 44:2273 (1992).
Abe, J., T. Nakano, Y. Nishii, T. Matsumoto, E. Ogata, and K. Ikeda, A novel vitamin D3 analog, 22-oxa-l,25-dihydroxyvitamin D3 inhibits growth of human breast cancer in vitro and in vivo without causing hypercalcemia, Endocrinology 129:832 (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Christakos, S. (1994). Vitamin D and Breast Cancer. In: Weisburger, E.K. (eds) Diet and Breast Cancer. Advances in Experimental Medicine and Biology, vol 364. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2510-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2510-3_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6068-1
Online ISBN: 978-1-4615-2510-3
eBook Packages: Springer Book Archive